Nureca Limited

Nureca Limited (NURECA) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Healthcare Equipment & Supplies›Medical Equipment & Supplies

nureca.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-04

Stock price
₹322.70
Market cap
308 Cr
Stock P/E
69.4
P/B
1.69
Dividend yield
1.6%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales31 Cr22 Cr17 Cr20 Cr31 Cr26 Cr32 Cr34 Cr38 Cr40 Cr35 Cr40 Cr
Operating expenses (approx.)30 Cr27 Cr21 Cr23 Cr34 Cr30 Cr31 Cr35 Cr34 Cr36 Cr41 Cr37 Cr
EBITDA1 Cr-4 Cr-4 Cr-2 Cr-2 Cr-4 Cr1 Cr-0.56 Cr3 Cr3 Cr-6 Cr3 Cr
OPM %4.4%-19.0%-26.1%-11.7%-7.6%-15.2%3.8%-1.6%8.7%8.2%-16.3%8.5%
Other income3 Cr6 Cr-1 Cr6 Cr3 Cr1 Cr2 Cr3 Cr2 Cr2 Cr1 Cr2 Cr
Interest0.08 Cr0.11 Cr0.18 Cr0.15 Cr0.27 Cr0.17 Cr0.62 Cr0.25 Cr0.46 Cr0.28 Cr0.30 Cr0.20 Cr
Depreciation0.59 Cr0.59 Cr0.60 Cr0.66 Cr0.62 Cr0.54 Cr0.52 Cr0.53 Cr0.54 Cr0.50 Cr0.45 Cr0.61 Cr
Profit before tax4 Cr0.94 Cr-6 Cr3 Cr-0.07 Cr-3 Cr2 Cr1 Cr5 Cr5 Cr-6 Cr4 Cr
Tax %26.0%82.5%35.9%36.5%-542.7%13.9%-20.3%34.0%21.1%19.9%-10.5%30.8%
Net profit3 Cr0.17 Cr-4 Cr2 Cr-0.48 Cr-3 Cr2 Cr0.81 Cr4 Cr4 Cr-6 Cr3 Cr
EPS (₹)₹2.90₹0.16₹-4.15₹1.66₹-0.48₹-2.80₹2.47₹0.81₹3.63₹3.91₹-6.45₹3.21

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales213 Cr256 Cr111 Cr92 Cr110 Cr147 CrSign in for TTM
Operating expenses (approx.)152 Cr200 Cr126 Cr102 Cr117 Cr147 CrSign in for TTM
EBITDA62 Cr56 Cr-15 Cr-10 Cr-8 Cr0.18 CrSign in for TTM
OPM %28.8%21.7%-13.5%-11.1%-6.9%0.1%Sign in for TTM
Other income3 Cr8 Cr7 Cr11 Cr12 Cr8 CrSign in for TTM
Interest2 Cr0.74 Cr0.45 Cr0.49 Cr1 Cr1 CrSign in for TTM
Depreciation0.42 Cr1 Cr2 Cr2 Cr2 Cr2 CrSign in for TTM
Profit before tax62 Cr61 Cr-11 Cr-3 Cr1 Cr5 CrSign in for TTM
Tax %25.6%26.3%23.2%29.5%37.0%58.2%Sign in for TTM
Net profit46 Cr45 Cr-8 Cr-2 Cr0.85 Cr2 CrSign in for TTM
EPS (₹)₹62.04₹44.96₹-8.25₹-1.79₹0.85₹2.11Sign in for TTM
Dividend payout %—11.1%——0.0%0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital10 Cr10 Cr10 Cr10 Cr10 Cr10 Cr
Reserves153 Cr193 Cr185 Cr183 Cr184 Cr171 Cr
Borrowings4 Cr4 Cr3 Cr0.48 Cr2 Cr0.72 Cr
Other liabilities19 Cr12 Cr8 Cr12 Cr13 Cr15 Cr
Total liabilities186 Cr219 Cr207 Cr205 Cr210 Cr196 Cr
Fixed assets (net)0.75 Cr4 Cr3 Cr3 Cr5 Cr11 Cr
CWIP0 Cr0 Cr0 Cr0.27 Cr0 Cr0 Cr
Investments0 Cr33 Cr59 Cr94 Cr1 Cr1 Cr
Loans & advances0.52 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Inventories37 Cr63 Cr34 Cr31 Cr40 Cr48 Cr
Trade receivables4 Cr3 Cr4 Cr2 Cr3 Cr8 Cr
Cash & bank17 Cr8 Cr0.50 Cr14 Cr3 Cr1 Cr
Other assets127 Cr108 Cr105 Cr62 Cr158 Cr128 Cr
Total assets186 Cr219 Cr207 Cr205 Cr210 Cr196 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity—1 Cr10 Cr-3 Cr-19 Cr3 Cr
Cash from investing—-3 Cr-16 Cr18 Cr8 Cr14 Cr
Cash from financing—-7 Cr-2 Cr-1 Cr-0.17 Cr-20 Cr
Net cash flow—-9 Cr-8 Cr14 Cr-11 Cr-2 Cr
Free cash flow (OCF − Capex)—-5 Cr10 Cr-4 Cr-23 Cr-4 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %38.4%30.4%-5.2%-1.1%1.3%3.5%
ROE %28.4%0.0%0.0%-0.9%0.0%0.0%
Debtor days641461119
Inventory days6390356711541287610
Days payable15751619321165
Cash conversion cycle548730659671086564
Debt / equity0.020.020.020.00250.010.0040
Current ratio9.6016.8521.0020.7715.328.32
Net debt / EBITDA0.000.00———-4.09

Compare with peers

Loading peers…